Gut microbiota and old age: Modulating factors and interventions for healthy longevity
- PMID: 32979504
- PMCID: PMC7510636
- DOI: 10.1016/j.exger.2020.111095
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Abstract
Our gut microbiota is a complex and dynamic ecosystem with a paramount role in shaping our metabolic and immunological functions. Recent research suggests that aging may negatively affect the composition, diversity, and function of our microbiota mainly due to alterations in diet and immunologic reactivity (i.e. immunosenescence), and increased incidence of certain diseases and, therefore, increased exposure to certain medication (e.g. antibiotics, proton pump inhibitors). In turn, this aging-related gut dysbiosis may contribute to the initiation and/or progress of other metabolic diseases, and consequently, to a decrease in healthy longevity. On the positive side, promising therapeutic interventions, such as diet supplementation with prebiotics, probiotics and synbiotics, or fecal microbiota transplantation, aimed to counteract these aging-related deleterious consequences, could improve our health, and extend our healthy lifespan. In this context, the current review aims to assess the latest progress in identifying the key elements affecting the gut microbiota of the older adults and their mechanism of action, and the effectiveness of the therapeutic interventions aimed at restoring the diversity and healthy functions of the gut microbiota in older individuals.
Keywords: Aging; Concomitant disease; Dietary alterations; Healthy longevity; Human gut microbiota; Therapeutic interventions.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Gut microbiota and aging-A focus on centenarians.Biochim Biophys Acta Mol Basis Dis. 2020 Jul 1;1866(7):165765. doi: 10.1016/j.bbadis.2020.165765. Epub 2020 Mar 10. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32169505
-
Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?Benef Microbes. 2017 Apr 26;8(2):179-192. doi: 10.3920/BM2016.0115. Epub 2016 Dec 23. Benef Microbes. 2017. PMID: 28008784 Review.
-
Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.Int J Mol Sci. 2023 Feb 4;24(4):3074. doi: 10.3390/ijms24043074. Int J Mol Sci. 2023. PMID: 36834485 Free PMC article. Review.
-
The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.Crit Rev Food Sci Nutr. 2021;61(2):337-355. doi: 10.1080/10408398.2020.1733483. Epub 2020 Mar 10. Crit Rev Food Sci Nutr. 2021. PMID: 32156153 Review.
-
Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.Expert Rev Gastroenterol Hepatol. 2022 Apr;16(4):321-332. doi: 10.1080/17474124.2022.2056017. Epub 2022 Mar 22. Expert Rev Gastroenterol Hepatol. 2022. PMID: 35303781 Review.
Cited by
-
Unveiling the Longevity Potential of Natural Phytochemicals: A Comprehensive Review of Active Ingredients in Dietary Plants and Herbs.J Agric Food Chem. 2024 Nov 13;72(45):24908-24927. doi: 10.1021/acs.jafc.4c07756. Epub 2024 Oct 31. J Agric Food Chem. 2024. PMID: 39480905 Free PMC article. Review.
-
The gut-brain axis in ischemic stroke: its relevance in pathology and as a therapeutic target.Neurol Res Pract. 2022 Nov 14;4(1):57. doi: 10.1186/s42466-022-00222-8. Neurol Res Pract. 2022. PMID: 36401322 Free PMC article. Review.
-
Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.Int J Chron Obstruct Pulmon Dis. 2024 Apr 5;19:873-886. doi: 10.2147/COPD.S436551. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38596203 Free PMC article.
-
Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.Front Endocrinol (Lausanne). 2022 Nov 3;13:1014670. doi: 10.3389/fendo.2022.1014670. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36407321 Free PMC article.
-
Pilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety.Contemp Clin Trials Commun. 2022 Mar 7;27:100906. doi: 10.1016/j.conctc.2022.100906. eCollection 2022 Jun. Contemp Clin Trials Commun. 2022. PMID: 35299780 Free PMC article.
References
-
- Aachary A.A., Prapulla S.G. Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Compr. Rev. Food Sci. Food Saf. 2011;10:2–16.
-
- Agrawal M., Aroniadis O.C., Brandt L.J., Kelly C., Freeman S., Surawicz C., Broussard E., Stollman N., Giovanelli A., Smith B., Yen E., Trivedi A., Hubble L., Kao D., Borody T., Finlayson S., Ray A., Smith R. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated clostridium difficile infection in 146 elderly individuals. J. Clin. Gastroenterol. 2016;50:403–407. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources